Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
BA3538 CynaropicrinSummary: Cynaropicrin, a sesquiterpene lactone, inhibits the release of tumor necrosis factor with values of 8.24 and 3.18 μM in murine and human macrophages, respectively. -
BA3539 ApratastatSummary: Apratastat (TMI-005) is an orally potent, non-selective and reversible inhibitor of the release of... -
BA3540 NecroX-7Summary: NecroX-7 is a potent free radical scavenger and a (high mobility group protein 1) inhibitor. -
BA3541 GSK2245035Summary: GSK2245035 is a potent, selective intranasal Toll-Like Receptor 7 agonist with preferential stimulation of type 1 interferon (IFN). -
BA3542 DCVCSummary: DCVC (S-[(1E)-1,2-Dichloroethenyl]-L-cysteine) is a bioactive metabolite of trichloroethylene (TCE). -
BA3543 IW927Summary: IW927 is a potent small molecule antagonist. -
BA3544 UCB-6876Summary: UCB-6876 is an inhibitor. -
BA3545 DuvakitugSummary: Duvakitug is a human IgG1-λ2 type monoclonal antibody targeting /TL1A. -
BA3546 HispidolSummary: Hispidol ((Z)-Hispidol) has the potential to study inflammatory bowel disease by inhibiting induced monocyte adhesion to colonic epithelial cells. -
BA3547 OzoralizumabSummary: Ozoralizumab (ATN-103) is an anti-humanized antibody.


